| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/329,173US20060116510A1 (en) | 2002-06-29 | 2006-01-11 | Isoflavone concentrates, as well as methods for their production |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2002/007194WO2004002469A1 (en) | 2002-06-29 | 2002-06-29 | Isoflavone concentrate and method for production thereof |
| US10/450,539US7208594B2 (en) | 2002-06-29 | 2002-06-29 | Isoflavone concentrates as well as methods for their production |
| US11/329,173US20060116510A1 (en) | 2002-06-29 | 2006-01-11 | Isoflavone concentrates, as well as methods for their production |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/469,541DivisionUS7155097B2 (en) | 2001-03-09 | 2002-03-09 | Fabrication of microstructured fibres |
| US10/450,539DivisionUS7208594B2 (en) | 2002-06-29 | 2002-06-29 | Isoflavone concentrates as well as methods for their production |
| PCT/EP2002/007194DivisionWO2004002469A1 (en) | 2002-06-29 | 2002-06-29 | Isoflavone concentrate and method for production thereof |
| Publication Number | Publication Date |
|---|---|
| US20060116510A1true US20060116510A1 (en) | 2006-06-01 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/450,539Expired - Fee RelatedUS7208594B2 (en) | 2002-06-29 | 2002-06-29 | Isoflavone concentrates as well as methods for their production |
| US11/329,173AbandonedUS20060116510A1 (en) | 2002-06-29 | 2006-01-11 | Isoflavone concentrates, as well as methods for their production |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/450,539Expired - Fee RelatedUS7208594B2 (en) | 2002-06-29 | 2002-06-29 | Isoflavone concentrates as well as methods for their production |
| Country | Link |
|---|---|
| US (2) | US7208594B2 (en) |
| EP (1) | EP1450786B1 (en) |
| JP (1) | JP2005531616A (en) |
| AT (1) | ATE312605T1 (en) |
| AU (1) | AU2002328824A1 (en) |
| CA (1) | CA2448513A1 (en) |
| DE (1) | DE50205310D1 (en) |
| DK (1) | DK1450786T3 (en) |
| ES (1) | ES2254725T3 (en) |
| IL (2) | IL158569A0 (en) |
| MX (1) | MXPA04002145A (en) |
| WO (1) | WO2004002469A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8551530B2 (en) | 2010-11-15 | 2013-10-08 | Humanetics Corporation | Nanoparticle isoflavone compositions and methods of making and using the same |
| US9084726B2 (en) | 2013-11-26 | 2015-07-21 | Humanetics Corporation | Suspension compositions of physiologically active phenolic compounds and methods of making and using the same |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005320281A (en)* | 2004-05-10 | 2005-11-17 | Shiratori Pharmaceutical Co Ltd | Promotor of insulin secretion and food and drink |
| EP1904042A2 (en)* | 2005-07-08 | 2008-04-02 | Aquanova Ag | Solubilsation products of an active ingredient extract |
| WO2007070523A2 (en)* | 2005-12-13 | 2007-06-21 | The Procter & Gamble Company | Personal care compositions comprising ppar. gamma. antagonists |
| EP2129373B1 (en)* | 2007-04-02 | 2013-05-22 | DSM IP Assets B.V. | Use of genistein for treating dry eye syndrome |
| US8637569B2 (en) | 2009-10-22 | 2014-01-28 | Api Genesis, Llc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| CA3023725C (en) | 2009-10-22 | 2021-09-14 | Vizuri Health Sciences Llc | Methods of producing hydrated flavonoids and use thereof in the preparation of topical compositions |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172128A (en)* | 1975-03-26 | 1979-10-23 | Erhard Thiele | Process of degrading and regenerating bone and tooth material and products |
| US4563350A (en)* | 1984-10-24 | 1986-01-07 | Collagen Corporation | Inductive collagen based bone repair preparations |
| US5563046A (en)* | 1993-08-02 | 1996-10-08 | Celtrix Pharmaceuticals, Inc. | Fusion polypeptides and proteins |
| US5608035A (en)* | 1994-02-02 | 1997-03-04 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US5635597A (en)* | 1994-05-27 | 1997-06-03 | Affymax Technologies, N.V. | Peptides that bind IL-2 receptors |
| US5643873A (en)* | 1992-05-06 | 1997-07-01 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1 |
| US5648458A (en)* | 1992-05-06 | 1997-07-15 | Affymax Technologies N.V. | Peptides and compounds that bind to ELAM-1 |
| US5654276A (en)* | 1995-06-07 | 1997-08-05 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-5 receptor |
| US5668110A (en)* | 1995-06-07 | 1997-09-16 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-5 receptor |
| US5674977A (en)* | 1993-02-05 | 1997-10-07 | The Ontario Cancer Institute | Branched synthetic peptide conjugate |
| US5679673A (en)* | 1992-09-24 | 1997-10-21 | The United States Of America, Represented By The Department Of Health And Human Services | Aralkyl bridged diazabicycloalkane derivatives for CNS disorders |
| US5679637A (en)* | 1989-04-27 | 1997-10-21 | The Salk Institute For Biological Studies | Fibroblast growth factor conjugates |
| US5684136A (en)* | 1992-05-18 | 1997-11-04 | Genentech, Inc. | Chimeric hepatocyte growth factor (HGF) ligand variants |
| US5728802A (en)* | 1992-05-06 | 1998-03-17 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1) |
| US5759515A (en)* | 1989-08-09 | 1998-06-02 | Rhomed Incorporated | Polyvalent peptide pharmaceutical applications |
| US5770704A (en)* | 1992-05-18 | 1998-06-23 | Genentech, Inc. | Receptor activation with inactive hepatocyte growth factor ligands |
| US5773569A (en)* | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
| US5786331A (en)* | 1994-02-02 | 1998-07-28 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US5789182A (en)* | 1990-12-20 | 1998-08-04 | The Children's Medical Center Corporation | System for assaying binding to a heparin-binding growth factor receptor |
| US5824702A (en)* | 1996-06-07 | 1998-10-20 | Mount Sinai School Of Medicine Of The City University Of New York | Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
| US5830851A (en)* | 1993-11-19 | 1998-11-03 | Affymax Technologies N.V. | Methods of administering peptides that bind to the erythropoietin receptor |
| US5861476A (en)* | 1994-02-02 | 1999-01-19 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US5866113A (en)* | 1996-05-31 | 1999-02-02 | Medtronic, Inc. | Medical device with biomolecule-coated surface graft matrix |
| US5869451A (en)* | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| US5880096A (en)* | 1994-02-02 | 1999-03-09 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US5902799A (en)* | 1989-04-23 | 1999-05-11 | The Trustees Of The University Of Pennsylvania | Methods of modulating tissue growth and regeneration |
| US5932462A (en)* | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5952474A (en)* | 1992-08-28 | 1999-09-14 | The Public Health Research Institute Of The City Of New York, Inc. | Fusion glycoproteins |
| US5955588A (en)* | 1997-12-22 | 1999-09-21 | Innerdyne, Inc. | Non-thrombogenic coating composition and methods for using same |
| US5965532A (en)* | 1996-06-28 | 1999-10-12 | Trustees Of Tufts College | Multivalent compounds for crosslinking receptors and uses thereof |
| US5989866A (en)* | 1996-10-16 | 1999-11-23 | Zymogenetics, Inc. | FGF homologs |
| US5994104A (en)* | 1996-11-08 | 1999-11-30 | Royal Free Hospital School Of Medicine | Interleukin-12 fusion protein |
| US6001364A (en)* | 1993-05-05 | 1999-12-14 | Gryphon Sciences | Hetero-polyoxime compounds and their preparation by parallel assembly |
| US6011002A (en)* | 1994-04-08 | 2000-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Circularly permuted ligands and circularly permuted chimeric molecules |
| US6030812A (en)* | 1992-11-24 | 2000-02-29 | G. D. Searle & Company | Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors |
| US6051648A (en)* | 1995-12-18 | 2000-04-18 | Cohesion Technologies, Inc. | Crosslinked polymer compositions and methods for their use |
| US6096343A (en)* | 1997-10-27 | 2000-08-01 | Gerhard Gergely | Instant calcium/soybean granules, their use and process for their preparation |
| US6121236A (en)* | 1998-03-24 | 2000-09-19 | The Children's Medical Center Corporation | Multivalent ligands which modulate angiogenesis |
| US6168784B1 (en)* | 1997-09-03 | 2001-01-02 | Gryphon Sciences | N-terminal modifications of RANTES and methods of use |
| US6174721B1 (en)* | 1994-08-05 | 2001-01-16 | Chiron Corporation | Chimeric proteins |
| US6174530B1 (en)* | 1993-05-05 | 2001-01-16 | Gryphon Sciences | Homogeneous polyoxime compositions and their preparation by parallel assembly |
| US6214795B1 (en)* | 1996-11-12 | 2001-04-10 | Praecis Pharmaceuticals, Inc. | Peptide compounds useful for modulating FGF receptor activity |
| US6251864B1 (en)* | 1995-06-07 | 2001-06-26 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| US6261565B1 (en)* | 1996-03-13 | 2001-07-17 | Archer Daniels Midland Company | Method of preparing and using isoflavones |
| US6284503B1 (en)* | 1993-08-20 | 2001-09-04 | University Of Utah Research Foundation | Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| US6294359B1 (en)* | 1985-09-12 | 2001-09-25 | Scios Inc. | Human basic fibroblast growth factor analog |
| US6300377B1 (en)* | 2001-02-22 | 2001-10-09 | Raj K. Chopra | Coenzyme Q products exhibiting high dissolution qualities |
| US6323323B1 (en)* | 1988-01-22 | 2001-11-27 | Zymogenetics, Inc. | Ligand-binding, dimerized polypeptide fusions |
| US6326468B1 (en)* | 1997-06-13 | 2001-12-04 | Gryphon Sciences | Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution |
| US6342591B1 (en)* | 1998-09-22 | 2002-01-29 | Biosurface Engineering Technologies, Inc. | Amphipathic coating for modulating cellular adhesion composition and methods |
| US6350731B1 (en)* | 1993-10-22 | 2002-02-26 | Trigen Limited | Platelet-derived growth factor analogues |
| US6377349B1 (en)* | 1998-03-30 | 2002-04-23 | Carl Zeiss Jena Gmbh | Arrangement for spectral interferometric optical tomography and surface profile measurement |
| US6451543B1 (en)* | 1998-08-31 | 2002-09-17 | Gryphon Sciences | Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| US6495718B1 (en)* | 1999-05-26 | 2002-12-17 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Method for suppressing sorbate- and/or sorbic acid-induced discoloration |
| US20030224996A1 (en)* | 1988-04-08 | 2003-12-04 | Stryker Corporation | Osteogenic devices |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2010894A1 (en)* | 1989-02-28 | 1990-08-31 | Isamu Horikoshi | Method of forming a suspension and composition formed by said method |
| WO1999038509A1 (en) | 1998-01-28 | 1999-08-05 | Dusan Miljkovic | Isoflavanoid formulations for oral administration |
| DE10104847B4 (en) | 2000-06-09 | 2006-12-21 | Aquanova German Solubilisate Technologies (Agt) Gmbh | Tocopherol concentrate and process for its preparation |
| DE10103454A1 (en)* | 2000-12-29 | 2002-08-01 | Aquanova Getraenketechnologie | Flavonoid concentrate useful in foods, body care products and cosmetics comprises a polysorbate and isoflavones and/or quercetin |
| DE50211435D1 (en) | 2001-02-11 | 2008-02-07 | Aquanova Ag | Process for the preparation of a drug concentrate and drug concentrate |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172128A (en)* | 1975-03-26 | 1979-10-23 | Erhard Thiele | Process of degrading and regenerating bone and tooth material and products |
| US4563350A (en)* | 1984-10-24 | 1986-01-07 | Collagen Corporation | Inductive collagen based bone repair preparations |
| US6294359B1 (en)* | 1985-09-12 | 2001-09-25 | Scios Inc. | Human basic fibroblast growth factor analog |
| US6323323B1 (en)* | 1988-01-22 | 2001-11-27 | Zymogenetics, Inc. | Ligand-binding, dimerized polypeptide fusions |
| US20030224996A1 (en)* | 1988-04-08 | 2003-12-04 | Stryker Corporation | Osteogenic devices |
| US5902799A (en)* | 1989-04-23 | 1999-05-11 | The Trustees Of The University Of Pennsylvania | Methods of modulating tissue growth and regeneration |
| US5679637A (en)* | 1989-04-27 | 1997-10-21 | The Salk Institute For Biological Studies | Fibroblast growth factor conjugates |
| US5759515A (en)* | 1989-08-09 | 1998-06-02 | Rhomed Incorporated | Polyvalent peptide pharmaceutical applications |
| US5789182A (en)* | 1990-12-20 | 1998-08-04 | The Children's Medical Center Corporation | System for assaying binding to a heparin-binding growth factor receptor |
| US5786322A (en)* | 1992-05-06 | 1998-07-28 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 |
| US5648458A (en)* | 1992-05-06 | 1997-07-15 | Affymax Technologies N.V. | Peptides and compounds that bind to ELAM-1 |
| US5728802A (en)* | 1992-05-06 | 1998-03-17 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1) |
| US5643873A (en)* | 1992-05-06 | 1997-07-01 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1 |
| US5770704A (en)* | 1992-05-18 | 1998-06-23 | Genentech, Inc. | Receptor activation with inactive hepatocyte growth factor ligands |
| US5684136A (en)* | 1992-05-18 | 1997-11-04 | Genentech, Inc. | Chimeric hepatocyte growth factor (HGF) ligand variants |
| US5952474A (en)* | 1992-08-28 | 1999-09-14 | The Public Health Research Institute Of The City Of New York, Inc. | Fusion glycoproteins |
| US5679673A (en)* | 1992-09-24 | 1997-10-21 | The United States Of America, Represented By The Department Of Health And Human Services | Aralkyl bridged diazabicycloalkane derivatives for CNS disorders |
| US6030812A (en)* | 1992-11-24 | 2000-02-29 | G. D. Searle & Company | Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors |
| US5674977A (en)* | 1993-02-05 | 1997-10-07 | The Ontario Cancer Institute | Branched synthetic peptide conjugate |
| US6001364A (en)* | 1993-05-05 | 1999-12-14 | Gryphon Sciences | Hetero-polyoxime compounds and their preparation by parallel assembly |
| US6217873B1 (en)* | 1993-05-05 | 2001-04-17 | Gryphon Sciences | Polyoxime compounds and their preparation |
| US6174530B1 (en)* | 1993-05-05 | 2001-01-16 | Gryphon Sciences | Homogeneous polyoxime compositions and their preparation by parallel assembly |
| US5563046A (en)* | 1993-08-02 | 1996-10-08 | Celtrix Pharmaceuticals, Inc. | Fusion polypeptides and proteins |
| US6284503B1 (en)* | 1993-08-20 | 2001-09-04 | University Of Utah Research Foundation | Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| US6350731B1 (en)* | 1993-10-22 | 2002-02-26 | Trigen Limited | Platelet-derived growth factor analogues |
| US5773569A (en)* | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
| US5830851A (en)* | 1993-11-19 | 1998-11-03 | Affymax Technologies N.V. | Methods of administering peptides that bind to the erythropoietin receptor |
| US5880096A (en)* | 1994-02-02 | 1999-03-09 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US5786331A (en)* | 1994-02-02 | 1998-07-28 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US5608035A (en)* | 1994-02-02 | 1997-03-04 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US5861476A (en)* | 1994-02-02 | 1999-01-19 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US5767234A (en)* | 1994-02-02 | 1998-06-16 | Affymax Technologies, N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US6011002A (en)* | 1994-04-08 | 2000-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Circularly permuted ligands and circularly permuted chimeric molecules |
| US5635597A (en)* | 1994-05-27 | 1997-06-03 | Affymax Technologies, N.V. | Peptides that bind IL-2 receptors |
| US6174721B1 (en)* | 1994-08-05 | 2001-01-16 | Chiron Corporation | Chimeric proteins |
| US5932462A (en)* | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5668110A (en)* | 1995-06-07 | 1997-09-16 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-5 receptor |
| US6251864B1 (en)* | 1995-06-07 | 2001-06-26 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| US5869451A (en)* | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| US5654276A (en)* | 1995-06-07 | 1997-08-05 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-5 receptor |
| US6051648A (en)* | 1995-12-18 | 2000-04-18 | Cohesion Technologies, Inc. | Crosslinked polymer compositions and methods for their use |
| US6261565B1 (en)* | 1996-03-13 | 2001-07-17 | Archer Daniels Midland Company | Method of preparing and using isoflavones |
| US5866113A (en)* | 1996-05-31 | 1999-02-02 | Medtronic, Inc. | Medical device with biomolecule-coated surface graft matrix |
| US5824702A (en)* | 1996-06-07 | 1998-10-20 | Mount Sinai School Of Medicine Of The City University Of New York | Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
| US5965532A (en)* | 1996-06-28 | 1999-10-12 | Trustees Of Tufts College | Multivalent compounds for crosslinking receptors and uses thereof |
| US5989866A (en)* | 1996-10-16 | 1999-11-23 | Zymogenetics, Inc. | FGF homologs |
| US5994104A (en)* | 1996-11-08 | 1999-11-30 | Royal Free Hospital School Of Medicine | Interleukin-12 fusion protein |
| US6214795B1 (en)* | 1996-11-12 | 2001-04-10 | Praecis Pharmaceuticals, Inc. | Peptide compounds useful for modulating FGF receptor activity |
| US6326468B1 (en)* | 1997-06-13 | 2001-12-04 | Gryphon Sciences | Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution |
| US6168784B1 (en)* | 1997-09-03 | 2001-01-02 | Gryphon Sciences | N-terminal modifications of RANTES and methods of use |
| US6096343A (en)* | 1997-10-27 | 2000-08-01 | Gerhard Gergely | Instant calcium/soybean granules, their use and process for their preparation |
| US5955588A (en)* | 1997-12-22 | 1999-09-21 | Innerdyne, Inc. | Non-thrombogenic coating composition and methods for using same |
| US6235716B1 (en)* | 1998-03-24 | 2001-05-22 | Children's Medical Center Corporation | Multivalent ligands which modulate angiogenesis |
| US6121236A (en)* | 1998-03-24 | 2000-09-19 | The Children's Medical Center Corporation | Multivalent ligands which modulate angiogenesis |
| US6377349B1 (en)* | 1998-03-30 | 2002-04-23 | Carl Zeiss Jena Gmbh | Arrangement for spectral interferometric optical tomography and surface profile measurement |
| US6451543B1 (en)* | 1998-08-31 | 2002-09-17 | Gryphon Sciences | Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| US6342591B1 (en)* | 1998-09-22 | 2002-01-29 | Biosurface Engineering Technologies, Inc. | Amphipathic coating for modulating cellular adhesion composition and methods |
| US6495718B1 (en)* | 1999-05-26 | 2002-12-17 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Method for suppressing sorbate- and/or sorbic acid-induced discoloration |
| US6300377B1 (en)* | 2001-02-22 | 2001-10-09 | Raj K. Chopra | Coenzyme Q products exhibiting high dissolution qualities |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8551530B2 (en) | 2010-11-15 | 2013-10-08 | Humanetics Corporation | Nanoparticle isoflavone compositions and methods of making and using the same |
| US8900635B2 (en) | 2010-11-15 | 2014-12-02 | Humanetics Corporation | Nanoparticle isoflavone compositions and methods of making and using the same |
| US9308167B2 (en) | 2010-11-15 | 2016-04-12 | Humanetics Corporation | Nanoparticle isoflavone compositions and methods of making and using the same |
| US9636322B2 (en) | 2010-11-15 | 2017-05-02 | Humanetics Corporation | Nanoparticle isoflavone compositions and methods of making and using the same |
| US9724325B2 (en) | 2010-11-15 | 2017-08-08 | Humanetics Corporation | Nanoparticle isoflavone compositions and methods of making and using the same |
| US10039739B2 (en) | 2010-11-15 | 2018-08-07 | Humanetics Corporation | Nanoparticle isoflavone compositions and methods of making and using the same |
| US10729674B2 (en) | 2010-11-15 | 2020-08-04 | Humanetics Corporation | Nanoparticle isoflavone compositions and methods of making and using the same |
| US9084726B2 (en) | 2013-11-26 | 2015-07-21 | Humanetics Corporation | Suspension compositions of physiologically active phenolic compounds and methods of making and using the same |
| US9387171B2 (en) | 2013-11-26 | 2016-07-12 | Humanetics Corporation | Suspension compositions of physiologically active phenolic compounds and methods of making and using the same |
| US9782384B2 (en) | 2013-11-26 | 2017-10-10 | Humanetics Corporation | Suspension compositions of physiologically active phenolic compounds and methods of making and using the same |
| US9937148B2 (en) | 2013-11-26 | 2018-04-10 | Humanetics Corporation | Suspension compositions of physiologically active phenolic compounds and methods of making and using the same |
| US10314812B2 (en) | 2013-11-26 | 2019-06-11 | Humanetics Corporation | Suspension compositions of physiologically active phenolic compounds and methods of making and using the same |
| Publication number | Publication date |
|---|---|
| AU2002328824A1 (en) | 2004-01-19 |
| DE50205310D1 (en) | 2006-01-19 |
| ATE312605T1 (en) | 2005-12-15 |
| ES2254725T3 (en) | 2006-06-16 |
| CA2448513A1 (en) | 2003-12-29 |
| JP2005531616A (en) | 2005-10-20 |
| WO2004002469A1 (en) | 2004-01-08 |
| HK1071512A1 (en) | 2005-07-22 |
| US20040220116A1 (en) | 2004-11-04 |
| MXPA04002145A (en) | 2005-03-07 |
| IL158569A (en) | 2008-12-29 |
| DK1450786T3 (en) | 2006-04-18 |
| IL158569A0 (en) | 2004-05-12 |
| US7208594B2 (en) | 2007-04-24 |
| EP1450786B1 (en) | 2005-12-14 |
| EP1450786A1 (en) | 2004-09-01 |
| Publication | Publication Date | Title |
|---|---|---|
| US20060116510A1 (en) | Isoflavone concentrates, as well as methods for their production | |
| CN105228470B (en) | Vitamin E soluble derivative preparation and composition comprising it | |
| Stanisavljević et al. | Antioxidant and antiproliferative activity of chokeberry juice phenolics during in vitro simulated digestion in the presence of food matrix | |
| Yang | Brazil nuts and associated health benefits: A review | |
| Fraga et al. | Basic biochemical mechanisms behind the health benefits of polyphenols | |
| O'Keefe et al. | Soybean nutrition | |
| Tew et al. | A diet high in wheat fiber decreases the bioavailability of soybean isoflavones in a single meal fed to women | |
| JP4668553B2 (en) | Epigallocatechin dimer and trimer having lipase inhibitory activity and / or antioxidant activity | |
| EP0914111A2 (en) | Method for the prevention and treatment of cachexia and anorexia | |
| CN104427887A (en) | Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids | |
| Pejčić et al. | The polyphenols as potential agents in prevention and therapy of prostate diseases | |
| Kaharso et al. | Quality improvement of soymilk as influenced by anaerobic grinding method and calcium addition | |
| US6251420B1 (en) | Isoflavanoid formulations for oral administration | |
| JP2005525335A (en) | N-acyl-phosphatidyl-ethanolamines and / or mixtures of N-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids | |
| Sanz et al. | Release, partitioning and stability of isoflavones from enriched custards during mouth, stomach and intestine in vitro simulations | |
| CN105072925A (en) | A composition for enhancing newborn infant cognitive, brain and/or cns development and method of using same | |
| US5932221A (en) | Genistin-enriched fraction from soy meal | |
| JP2003153650A (en) | Edible oil and fat, and food product using the same | |
| WO2005115472A2 (en) | Compositions comprising gamma-linolenic acid and iodine for improving breast health in women | |
| HK1071512B (en) | Isoflavone concentrate and method for production thereof | |
| Antoine et al. | Impact of pulses, starches and meat on vitamin D and K postprandial responses in mice | |
| Wijayanti et al. | Administration of Mung Bean Extract (Phaseolus radiatus) in Increasing Hb and Ferritin Level and Decreasing Malondyaldehide (MDA) Level in Anaemic Rats. | |
| MX2008001791A (en) | Food product and fortification system therefor. | |
| JPH119221A (en) | Antiosteoporotic composition | |
| WO2001087315A1 (en) | Treatment or prevention of metabolic bone disorder |
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment | Owner name:AQUANOVA AG, GERMANY Free format text:CHANGE OF NAME;ASSIGNOR:AQUANOVA GERMAN SOLUBILISATE TECHNOLOGIES (AGT) GMBH;REEL/FRAME:019353/0674 Effective date:20061026 | |
| STCB | Information on status: application discontinuation | Free format text:ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |